ID
12152
Description
An open-label, multicenter, randomized, comparative, phase III study to evaluate the efficacy and safety of rituximab plus fludarabine and cyclophosphamide (FCR) versus fludarabine and cyclophosphamide alone (FC) in previously treated patients with CD20 positive B-cell chronic lymphocytic leukemia (CLL). NCT00090051 BO17072
Keywords
Versions (2)
- 10/1/15 10/1/15 -
- 10/28/15 10/28/15 -
Uploaded on
October 1, 2015
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0 Legacy
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
CLL Follow-Up NCT00090051 BO17072
Follow-Up Study completion Chronic Lymphocytic Leukemia NCT00090051 BO17072
Description
Bone marrow sampling for molecular response
Alias
- UMLS CUI-1
- C0005953
Description
Date of 1st confirmation (Sample number 501)
Data type
date
Measurement units
- dd/mm/yy
Description
Remarks of 1st confirmation (Sample number 501)
Data type
text
Description
Date of 2nd confirmation (Sample number 502)
Data type
date
Measurement units
- dd/mm/yy
Description
Remarks of 2nd confirmation (Sample number 502)
Data type
text
Description
Blood sampling for molecular response
Alias
- UMLS CUI-1
- C0005953
Description
Date of 1st confirmation (Sample number 601)
Data type
date
Measurement units
- dd/mm/yy
Description
Remarks of 1st confirmation (Sample number 601)
Data type
text
Description
Date of 2nd confirmation (Sample number 602)
Data type
date
Measurement units
- dd/mm/yy
Description
Remarks of 2nd confirmation (Sample number 602)
Data type
text
Description
Completion of follow-up period
Alias
- UMLS CUI-1
- C0016441
Description
Study completion
Description
Date of last contact
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0011008
Description
Study completion
Data type
boolean
Description
Reason for no completion
Data type
integer
Description
Specify violation of selection criteria
Data type
text
Description
Specify other protocol violation
Data type
text
Description
Specify other reason
Data type
text
Description
Survival visit
Description
Date of contact
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C1705415
Description
Survival status
Data type
integer
Description
Date of Death
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C1148348
Description
Date of last contact
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1]
- C0805839
Description
Cause of death
Data type
integer
Alias
- UMLS CUI [1]
- C0007465
Description
Specify other cause of death
Data type
text
Alias
- UMLS CUI [1]
- C0007465
Description
Disease progression
Data type
integer
Alias
- UMLS CUI [1]
- C0242656
Description
Date of progressive disease
Data type
date
Measurement units
- dd/mm/yy
Alias
- UMLS CUI [1,1]
- C1335499
- UMLS CUI [1,2]
- C0011008
Similar models
Follow-Up Study completion Chronic Lymphocytic Leukemia NCT00090051 BO17072
C1705415 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])